Tag: Miltenyi Biotec

Home / Miltenyi Biotec

Categories

Novel treatment target for lymphoma patients who relapse after CAR-T therapy

Feb 2023: The results of the trial demonstrated that a novel chimeric antigen receptor T-cell therapy elicited a response in adults with advanced large B-cell lymphoma who had relapsed following prio...
miltenyi-biotec

Scan the code